NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

BPs who are interested in a biotech have no problem ponying up the big bucks required. No BP would put up money for an insolvent OTC penny stock with dubious clinical trial data. They have clear understanding that NWBO tossed out their failed primary endpoint and redid the trial after it was virtually completed.
No BP BizDev person would would bet their career on something all their clinical people would laugh at.